seekingalpha.com
/4 days ago
Latest updates for Bmy
Fresh curated links around BMY are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Bristol Myers Squibb's Breakout Is Here: Portfolio Renewal Gaining Momentum
- TG Therapeutics: Briumvi's Growth Attracts Buyout Rumors
- Brookmount Explorations Inc. (BMXI) Completes Acquisition of Mentor AI Corp
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
newswire.com
/1 month ago
Brookmount Explorations Inc. (BMXI) Completes Acquisition of Mentor AI Corp
All-stock acquisition marks the Company's entry into artificial-intelligence technologies
pharmexec.com
/1 month ago
<![CDATA[AstraZeneca and Bristol Myers Squibb Held Merger Talks: Report]]>
njbiz.com
/4 weeks ago
NJ-based BMS to build $2.3B Texas manufacturing campus
Lawrenceville-based BMS will invest $2.3 billion to build a 600,000-square-foot Houston manufacturing campus expected to create 500 skilled jobs. The post NJ-based BMS to build $2....
cafepharma.com
/1 month ago
BMS SUCKS!!!
BMS SUCKS!!! Anonymous (not verified) Sun, 07/12/2026 - 12:13 field_thread_url https://cafepharma.com/boards/threads/bms-sucks.660695/ b...
investing.com
/1 month ago
Bristol-Myers Squibb stock rating held at Market Perform by Raymond James
pharmexec.com
/1 month ago
<![CDATA[Pharmaceutical Executive Daily: AstraZeneca and Bristol Myers Squibb Held Merger Talks]]>
seekingalpha.com
/1 month ago
Bimini outlines NOL runway to $5.5M by end of 2028 while integrating TJIM’s $1.7B AUM platform
biopharmadive.com
/3 weeks ago
Bristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from Celgene
The clearance of Zenbexus is the first for a group of protein-degrading “CELMoD” medicines that could help Bristol Myers rejuvenate a key drug franchise.
fiercebiotech.com
/1 day ago
Bristol Myers’ pivotal CAR-T multiple myeloma trial hits primary endpoint
A pivotal trial of Bristol Myers Squibb’s GPRC5D-directed CAR-T cell therapy has hit its primary endpoint, furthering the drugmaker’s efforts to challenge Johnson & Johnson for...
pharmexec.com
/1 week ago
<![CDATA[ Eli Lilly to Acquire Merida Biosciences for $2.8 Billion ]]>
pharmexec.com
/4 weeks ago
<![CDATA[Everything You Need to Know About the AstraZeneca–Bristol Myers Squibb Merger Rumors]]>
roi-nj.com
/4 weeks ago
Bristol Myers Squibb says it will build $2.3B manufacturing campus in Houston
Bristol Myers Squibb announced Aug. 10 the selection of Houston as the site for a state-of-the-art multi-modal manufacturing campus, representing an approximately $2.3 billion inve...
crypto.news
/1 month ago
BMNR stock rises over 10% as BitMine adds 9,946 ETH
BitMine Immersion Technologies expanded its Ethereum treasury and accelerated its share buybacks last week, while BMNR stock jumped nearly 11% on Monday as ETH reclaimed $1,900. Bi...
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Bmy
seekingalpha.com
Recent coverage from public sources
Public source
cafepharma.com
Recent coverage from public sources
Public source
crypto.news
Recent coverage from public sources
Public source
finance.yahoo.com
Recent coverage from public sources
Public source
njbiz.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source